Quick Summary
Venetomed 10mg Tablet
Last updated on 13 Nov 2026 | 06:28 AM (IST)
₹262
MRP: ₹319
(You Save ₹57)
2 TABLET(s) IN A STRIP
18% OFF
₹262
MRP: ₹319.00
Inclusive of all taxes
18% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Venmiges 10 Tablet
SUN PHARMACEUTI...
₹ 133.43/tablet
2% costlier
Claxven 10mg Tablet
LUCIEN LIFE SCI...
₹ 207.07/tablet
59% costlier
Venclexta 10mg Tablet
ABBVIE THERAPEU...
₹ 411.00/tablet
214% costlier
Better Service Satisfied Customers
Introduction
Venetomed 10mg Tablet contains Venetoclax 10 mg as its active ingredient. It belongs to a class of anticancer medicines called B-cell lymphoma 2 (BCL-2) inhibitors. It is an oral prescription medicine used as part of treatment regimens for certain blood cancers.
Venetomed is available as a 10 mg tablet. Venetoclax treatment is started under specialist supervision, with the dose adjusted gradually according to the type of cancer, treatment regimen and patient's response.
Uses of Venetomed 10mg Tablet
Venetomed 10mg Tablet is used for:
Chronic lymphocytic leukaemia (CLL): Used alone or in combination with other anticancer medicines to treat adults with this type of blood cancer.
Small lymphocytic lymphoma (SLL): Used as part of treatment regimens for adults with this type of lymphoma.
Acute myeloid leukaemia (AML): Used in combination with medicines such as Azacitidine, Decitabine or low-dose Cytarabine in eligible adults who are unsuitable for intensive chemotherapy.
The doctor decides the appropriate treatment combination, dose and duration based on the type of cancer and the patient's medical condition.
How Venetomed 10mg Tablet Works
Venetomed 10mg Tablet contains Venetoclax, which blocks a protein called B-cell lymphoma 2 (BCL-2). This protein helps cancer cells survive by preventing their natural cell death.
In certain blood cancers, BCL-2 is present in increased amounts, allowing abnormal cells to survive for longer than they should. Venetoclax blocks this protein and helps activate the natural process of programmed cell death (apoptosis). This reduces the survival of cancer cells and helps control the disease.
Interactions of Venetomed 10mg Tablet with Other Medicines
Some medicines can change the amount of Venetoclax in the body, potentially affecting its safety and effectiveness. Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and herbal supplements you take.
Antifungal medicines: Medicines such as Itraconazole, Ketoconazole, Posaconazole and Voriconazole can increase Venetoclax levels and the risk of side effects. Dose adjustments or alternative medicines may be required.
Antibiotics: Medicines such as Clarithromycin and Erythromycin can increase Venetoclax levels. Your doctor may need to adjust the treatment dose.
Antiviral medicines: Ritonavir-containing medicines can increase Venetoclax exposure and may require dose modification.
Antiepileptic medicines: Carbamazepine and Phenytoin can reduce Venetoclax levels and make the treatment less effective. Their combined use should generally be avoided.
Tuberculosis medicines: Rifampicin can reduce Venetoclax levels and affect treatment effectiveness. Concomitant use should be avoided.
Herbal supplements: St John's wort can reduce Venetoclax levels and should not be used during treatment.
Avoid grapefruit, Seville oranges and starfruit during treatment, as they can increase Venetoclax levels. Do not start, stop or change any medicine without consulting your doctor.
Storage Conditions
Store Venetomed 10mg Tablet according to the instructions provided on the product packaging.
Keep the tablets in their original packaging until required.
Keep the medicine out of the sight and reach of children.
Do not use the medicine after its expiry date.
How to Use
Take Venetomed 10mg Tablet exactly as prescribed by your doctor.
Swallow the tablet whole with water. Do not chew or crush it unless your doctor or pharmacist advises otherwise.
Take the tablet with a meal and water, preferably at the same time each day.
The treatment dose is usually increased gradually to reduce the risk of tumour lysis syndrome (TLS), a condition that occurs when cancer cells break down rapidly and release their contents into the bloodstream.
The starting dose and dose-escalation schedule depend on the type of cancer and the medicines used in combination.
Your doctor may recommend adequate fluid intake, preventive medicines and regular blood tests before and during treatment.
If you miss a dose, follow your doctor's instructions. Do not take an extra dose to compensate without medical advice.
Do not change the dose or stop treatment without consulting your doctor.
Safety Advice
Pregnancy
Venetoclax may harm the developing baby. It is not recommended during pregnancy. Women who can become pregnant should use effective contraception during treatment and for at least 30 days after the last dose. Inform your doctor if you are pregnant, planning a pregnancy or become pregnant during treatment.
Breast Feeding
It is not known whether Venetoclax passes into human breast milk. However, a risk to the breastfeeding baby cannot be excluded. Breastfeeding should be discontinued during treatment.
Lungs
Venetoclax can increase the risk of infections, including pneumonia, particularly when it reduces white blood cell counts. Inform your doctor if you have an existing lung condition or develop a persistent cough, fever or difficulty breathing during treatment.
Liver
Inform your doctor if you have liver disease before starting treatment. Patients with severe liver impairment may require a dose adjustment and closer monitoring while taking Venetoclax.
Alcohol
Discuss alcohol consumption with your doctor during treatment. Your doctor can advise whether it is appropriate based on your overall health, liver function and other medicines being used.
Driving
Venetoclax may cause fatigue or dizziness in some people. Avoid driving or operating machinery if you experience these symptoms or feel unable to do so safely.
Side Effects
Venetomed 10mg Tablet may cause side effects in some people, although not everyone experiences them. The side effects can also vary depending on the type of cancer and other medicines used alongside Venetoclax.
Common side effects
Nausea
Diarrhoea
Vomiting
Constipation
Fatigue
Anaemia (low red blood cell count)
Neutropenia (low white blood cell count)
Thrombocytopenia (low platelet count)
Upper respiratory tract infections
Pneumonia
Serious side effects
Contact your doctor immediately if you experience symptoms of serious complications, including:
Tumour lysis syndrome: Nausea, vomiting, muscle cramps, unusual tiredness, confusion or irregular heartbeat.
Severe infections: Fever, chills, persistent cough or difficulty breathing.
Severe reduction in blood cells: Unusual bleeding, easy bruising, persistent fever or extreme weakness.
Tumour lysis syndrome can occur when cancer cells break down rapidly, particularly during the initial stages of treatment and dose escalation. It requires prompt medical attention.
Expert Tips
Take Venetomed 10mg Tablet exactly as prescribed and follow the dose-escalation schedule given by your oncologist.
Do not increase the dose on your own, even if you feel well.
Maintain adequate hydration as advised by your doctor, especially during the initial treatment period.
Attend all scheduled blood tests to monitor blood cell counts, kidney function and electrolyte levels.
Report fever, chills, unusual bleeding or signs of infection promptly.
Avoid grapefruit, Seville oranges and starfruit during treatment.
Inform your doctor about all medicines and herbal supplements you take to prevent potentially harmful interactions.
Avoid live vaccines during treatment unless your specialist confirms they are appropriate.
Inform your doctor if you are pregnant, planning a pregnancy or breastfeeding.
Do not stop treatment or restart it after an interruption without consulting your oncologist.
FAQs
Q1.
What is Venetomed 10mg Tablet used for?
Venetomed 10mg Tablet contains Venetoclax 10 mg and is used to treat certain blood cancers, including chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL) and acute myeloid leukaemia (AML). It may be prescribed alone or in combination with other anticancer medicines, depending on the condition.
Q2.
What are the uses of Venetomed 10 Tablet?
Venetomed 10 Tablet is used as part of treatment regimens for certain blood cancers, including CLL, SLL and AML. The doctor determines the appropriate treatment combination based on the patient's condition.
Q3.
Is Venetomed 10 mg used for blood cancer?
Yes. Venetomed 10 mg contains Venetoclax, an anticancer medicine used to treat certain blood cancers, such as CLL, SLL and AML. It works by blocking the BCL-2 protein, which helps cancer cells survive.
Q4.
What is the strength of Venetomed 10mg Tablet?
Each Venetomed 10mg Tablet contains 10 mg of Venetoclax. The dose is gradually increased under medical supervision according to the prescribed treatment schedule.
Q5.
What is the price of Venetomed 10?
The price of Venetomed 10 may vary depending on the manufacturer, pack size and pharmacy. Check the product listing or contact the pharmacy for the latest price.
Q6.
How much does Venetomed 10 mg cost?
The cost of Venetomed 10 mg can vary depending on the pack size and current availability. Check the product page for the latest pricing information before purchasing.
Q7.
How should Venetomed 10mg Tablet be taken?
Swallow the tablet whole with water and a meal. Take it at approximately the same time each day, following your doctor's prescribed schedule.
Q8.
Can Venetomed 10mg Tablet affect blood cell counts?
Yes. Venetoclax can reduce white blood cells, red blood cells and platelets. Your doctor will arrange regular blood tests to monitor these levels during treatment.
Q9.
Can Venetomed 10mg Tablet be stopped suddenly?
Do not stop Venetomed 10mg Tablet without consulting your oncologist. Your doctor will decide whether treatment needs to be interrupted, adjusted or discontinued based on your condition and response to treatment.
Fact Box
Molecule name | Venetoclax |
Therapeutic class | Anticancer medicine |
Pharmacological class | B-cell lymphoma 2 (BCL-2) inhibitor |
Indications | Chronic lymphocytic leukaemia, small lymphocytic lymphoma and acute myeloid leukaemia |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Prakruthi Madhusudan
MSc Bioinformatics

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 13 Nov 2026 | 06:28 AM (IST)

Want to know more?
Read Our Editorial Policy








